Skip to main content
SpringerLink
Log in

Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

We examined the influence of alleles at the HLA loci, previously found to be associated with multiple sclerosis (MS) in Sardinia, on the clinical course of the disease in 835 relapsing (R) and 100 primary progressive (PP) patients. Multivariate analysis was carried out on predisposing 0301 or non–associated DPB1 alleles, susceptible or non–associated DRB1–DQB1 haplotypes, both predisposing and non–predisposing, and negatively and non–negatively associated D6S1683 alleles, taking interaction between them into account. Intra–patient analysis showed that the presence of the susceptible or protective D6S1683 allele interacting with predisposing DP 0301 modulated risk of PP disease. These findings suggest that a locus telomeric to HLA class I exerts an effect on alleles at the DPB1 locus in modulating disease course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barcellos LF, Oksenberg JR, Green AJ, et al. (2002) Genetic basis for clinical expression in multiple sclerosis. Brain 125:150–158

    CAS  PubMed  Google Scholar 

  2. Barcellos LF, Oksenberg JR, Begovich AB, et al. (2003) HLA–DR2 effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710–716

    Article  CAS  PubMed  Google Scholar 

  3. Bruck W, Lucchinetti C, Lassmann H (2002) The pathology of primary progressive multiple sclerosis. Mult Scler 8:93–97

    CAS  PubMed  Google Scholar 

  4. Coraddu F, Lai M, Mancosu C, et al. (2003) A genome–wide screen for linkage disequilibrium in Sardinian multiple sclerosis. J Neuroimmunol 143:120–123

    Article  CAS  PubMed  Google Scholar 

  5. De la Concha EG, Arroyo R, Crusius JB, et al. (1997) Combined effect of HLA–DRB1*1501 and interleukin–1 receptor antagonist gene allele–2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol 80:172–178

    Article  CAS  PubMed  Google Scholar 

  6. Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377:150–151

    Article  CAS  PubMed  Google Scholar 

  7. Ebers GC, Kukay K, Bulman DE, et al. (2001) A full genome search in multiple sclerosis. Neurogenetics 3:145–151

    PubMed  Google Scholar 

  8. Filippi M, Iannucci G, Tortorella C, et al. (1999) Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 52:588–594

    CAS  PubMed  Google Scholar 

  9. Fogdell–Hahn A, Ligers A, Gronning M, Hillert J, Olerup O (2000) Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55:140–148

    CAS  PubMed  Google Scholar 

  10. Granieri E, Casetta I, Govoni V, et al. (2000) The increasing incidence and prevalence of MS in a Sardinian province. Neurology 55:842–848

    CAS  PubMed  Google Scholar 

  11. Haines JL, Ter–Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, et al. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469–471

    Article  CAS  PubMed  Google Scholar 

  12. Harbo HF, Lie BA, Sawcer S, Celius EG, et al. (2004) Genes in the HLA class I region may contribute to the HLA class II–associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63:237–247

    Article  CAS  PubMed  Google Scholar 

  13. Hensiek AE, Sawcer SJ, Feakes R, et al. (2002) HLA–DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 72:184–187

    CAS  PubMed  Google Scholar 

  14. Hensiek AE, Roxburgh R, Smilie B, et al. (2003) Updated results of the United Kingdom linkage–based genome screen in multiple sclerosis. J Neuroimmunol 143:25–30

    Article  CAS  PubMed  Google Scholar 

  15. Kuokkanen S, Gschwend M, Rioux JD, et al. (1997) Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 61:1379–1387

    Article  CAS  PubMed  Google Scholar 

  16. Lampis R, Morelli L, Congia M, et al. (2000) The inter–regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case–control association studies in complex diseases. Hum Mol Genet 9:2959–2965

    Article  CAS  PubMed  Google Scholar 

  17. Lampis R, Morelli L, De Virgiliis S, Congia M, Cucca F (2000) The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens 56:515–521

    Article  CAS  PubMed  Google Scholar 

  18. Lublin FD, Reingold SC (1996) National Multiple Sclerosis. Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907–911

    CAS  PubMed  Google Scholar 

  19. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717

    Article  CAS  PubMed  Google Scholar 

  20. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F (1998) DRB1–DQA1–DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7:1235–1237

    Article  CAS  PubMed  Google Scholar 

  21. Marrosu MG, Murru R, Murru MR, et al. (2001) Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 10:2907–2916

    Article  CAS  PubMed  Google Scholar 

  22. Mastermann T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J (2000) HLA–DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 48:211–219

    Google Scholar 

  23. McDonald WI, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127

    Article  CAS  PubMed  Google Scholar 

  24. McDonnell GV, Hawkins SA (2002) Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J Neurol Sci 199:1–15

    Article  CAS  PubMed  Google Scholar 

  25. Mustafa M, Vingsbo C, Olsson T, Issazadeh S, Ljungdahl A, Holmdahl R (1994) Protective influences on Experimental Autoimmune Encephalomyelitis by MHC class I and class II alleles. J Immunol 153:3337–3344

    CAS  PubMed  Google Scholar 

  26. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI (1994) A comparison of pathology of primary and secondary progressive multiple sclerosis. Brain 117:759–765

    PubMed  Google Scholar 

  27. Schlesselman J (1982) Case–Control Studies. Oxford University Press, pp 227–269

  28. Selvin S (1996) Statistical Analysis of Epidemiologic Data. Oxford University Press, 2nd edition, pp 243–269

  29. Stevenson VL, Miller DH, Rovaris M, et al. (1999) Primary and transitional progressive MS: a clinical and MRI cross–sectional study. Neurology 52:839–845

    CAS  PubMed  Google Scholar 

  30. Suhy J, Rooney WD, Goodkin DE, et al. (2000) 1H–MRSI comparison of white matter and lesions in primary progressive and relapsing–remitting MS. Mult Scler 6:148–155

    Article  CAS  PubMed  Google Scholar 

  31. The Transatlantic Multiple Sclerosis Genetics Cooperative (2001) A metaanalysis of genomic screens in multiple sclerosis. Mult Scler 7:3–11

    Google Scholar 

  32. Thompson AJ, Kermode AG, Wicks D, et al. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29:53–62

    Article  CAS  PubMed  Google Scholar 

  33. Thompson AJ, Montalban X, Barkhof F, et al. (2001) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831–835

    Google Scholar 

  34. Thomson G (1995) Mapping disease genes: family based association studies. Am J Hum Genet 57:487–498

    CAS  PubMed  Google Scholar 

  35. Von Büdingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP (2002) Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. PNAS 99:8207–8212

    PubMed  Google Scholar 

  36. Weinshenker BG, Santrach P, Bissonet AS, et al. (1998) Major histocompatibility complex class II alleles and the course and outcome of MSA population– based study. Neurology 51:742–747

    CAS  PubMed  Google Scholar 

  37. Weissert R, Wallstrom E, Storch MK, et al. (1998) MHC haplotype–dependent regulation of MOG–induced EAE in rats. J Clin Invest 102:1265–1273

    CAS  PubMed  Google Scholar 

  38. Yamasaki K, Horiuchi I, Minohara M, et al. (1999) HLA–DPB1*0501–associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122:1689–1696

    Article  PubMed  Google Scholar 

  39. Yu M, Kinkel P, Weinstock–Guttman B, Cook DJ, Tuohy VK (1998) HLA–DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum Immunol 59:15–24

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Sclerosi Multipla, Ospedale Binaghi, Via Is Guadazzonis, 2, 09126, Cagliari, Italy

    M. G. Marrosu M. D., E. Cocco, G. Costa, M. R. Murru, C. Mancosu, R. Murru & M. Lai

  2. Dipartimento di Salute Pubblica, University of Cagliari, Cagliari, Italy

    C. Sardu & P. Contu

Authors
  1. M. G. Marrosu M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Cocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. R. Murru
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Mancosu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Murru
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Sardu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Contu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. G. Marrosu M. D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marrosu, M.G., Cocco, E., Costa, G. et al. Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population. J Neurol 253, 208–213 (2006). https://doi.org/10.1007/s00415-005-0957-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0957-y

Key words

Search

Navigation